Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991;180(5):239-48.
doi: 10.1007/BF00202558.

Correlation of preS antigens and clinical status during chronic hepatitis B virus infection

Affiliations

Correlation of preS antigens and clinical status during chronic hepatitis B virus infection

G Taliani et al. Med Microbiol Immunol. 1991.

Abstract

The serum kinetics of preS1 and preS2 antigens has been evaluated in 38 serial samples from eight patients with chronic active (CAH) or chronic persistent (CPH) hepatitis, followed for 2-7 years (mean 4.4 years) in whom liver biopsy was performed at intervals, and in 46 samples from ten asymptomatic HBsAg carriers followed for 4-5 years (mean 4.6 years). Four patterns of preS behaviour have been observed: (1) persistently positive preS1 and preS2; (2) disappearance of preS2; (3) disappearance of both preS1 and preS2; and (4) persistently negative preS1 and preS2. Pattern 4 has been observed exclusively among healthy carriers, while seven out of eight chronic patients exhibited either pattern 1 or 2. Among the chronic patients, preS2 disappearance was accompanied or followed by alanine aminotransferase (ALT) normalization. The correlation of preS antigens with conventional viral replication markers showed that 100% of hepatitis B virus (HBV)-DNA-positive and 86.6% of HBeAg-positive sera were preS1/preS2 positive, while 61% of HBV-DNA-negative and 64% of HBeAg-negative sera were preS1/preS2 negative. Our data suggest that continuous monitoring of preS antigens in follow-up sera will allow for an improved prognostic evaluation of chronic HBV infection.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Virol. 1989 May;63(5):1981-8 - PubMed
    1. Science. 1985 Jun 7;228(4704):1195-9 - PubMed
    1. J Virol. 1984 Nov;52(2):396-402 - PubMed
    1. J Immunol. 1987 Jul 15;139(2):539-44 - PubMed
    1. Intervirology. 1987;28(1):14-25 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources